Low-dose contrast-enhanced MR angiography

Kambiz Nael; Roya Saleh; Gerhard Laub; J. Paul Finn

doi:10.1007/978-1-4419-1686-0_7

Low-dose contrast-enhanced MR angiography

Kambiz Nael, Roya Saleh, Gerhard Laub, J. Paul Finn

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Today, three-dimensional contrast-enhanced magnetic resonance angiography (CE-MRA) is a widely accepted and powerful diagnostic tool for assessment of almost all vascular territories. Its noninvasive nature and flexibility make CE-MRA an appealing alternative to digital subtraction angiography (DSA) or computed tomography angiography (CTA). In addition, compared to the iodinated contrast agents used in CTA and DSA, gadolinium-based contrast agents have long enjoyed an excellent safety record. In the past, there has been little motivation for, or emphasis on, dose reduction strategies.

Original language	English
Title of host publication	Magnetic Resonance Angiography
Subtitle of host publication	Principles and Applications
Publisher	Springer New York
Pages	107-112
Number of pages	6
ISBN (Electronic)	9781441916860
ISBN (Print)	9781441916853
DOIs	https://doi.org/10.1007/978-1-4419-1686-0_7
State	Published - 1 Jan 2012
Externally published	Yes

Access to Document

10.1007/978-1-4419-1686-0_7

Cite this

@inbook{6a0de783e2d4413c97c95bc4516bca59,

title = "Low-dose contrast-enhanced MR angiography",

abstract = "Today, three-dimensional contrast-enhanced magnetic resonance angiography (CE-MRA) is a widely accepted and powerful diagnostic tool for assessment of almost all vascular territories. Its noninvasive nature and flexibility make CE-MRA an appealing alternative to digital subtraction angiography (DSA) or computed tomography angiography (CTA). In addition, compared to the iodinated contrast agents used in CTA and DSA, gadolinium-based contrast agents have long enjoyed an excellent safety record. In the past, there has been little motivation for, or emphasis on, dose reduction strategies.",

author = "Kambiz Nael and Roya Saleh and Gerhard Laub and Finn, {J. Paul}",

year = "2012",

month = jan,

day = "1",

doi = "10.1007/978-1-4419-1686-0_7",

language = "English",

isbn = "9781441916853",

pages = "107--112",

booktitle = "Magnetic Resonance Angiography",

publisher = "Springer New York",

address = "United States",

}

TY - CHAP

T1 - Low-dose contrast-enhanced MR angiography

AU - Nael, Kambiz

AU - Saleh, Roya

AU - Laub, Gerhard

AU - Finn, J. Paul

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Today, three-dimensional contrast-enhanced magnetic resonance angiography (CE-MRA) is a widely accepted and powerful diagnostic tool for assessment of almost all vascular territories. Its noninvasive nature and flexibility make CE-MRA an appealing alternative to digital subtraction angiography (DSA) or computed tomography angiography (CTA). In addition, compared to the iodinated contrast agents used in CTA and DSA, gadolinium-based contrast agents have long enjoyed an excellent safety record. In the past, there has been little motivation for, or emphasis on, dose reduction strategies.

AB - Today, three-dimensional contrast-enhanced magnetic resonance angiography (CE-MRA) is a widely accepted and powerful diagnostic tool for assessment of almost all vascular territories. Its noninvasive nature and flexibility make CE-MRA an appealing alternative to digital subtraction angiography (DSA) or computed tomography angiography (CTA). In addition, compared to the iodinated contrast agents used in CTA and DSA, gadolinium-based contrast agents have long enjoyed an excellent safety record. In the past, there has been little motivation for, or emphasis on, dose reduction strategies.

UR - http://www.scopus.com/inward/record.url?scp=84954589271&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1686-0_7

DO - 10.1007/978-1-4419-1686-0_7

M3 - Chapter

AN - SCOPUS:84954589271

SN - 9781441916853

SP - 107

EP - 112

BT - Magnetic Resonance Angiography

PB - Springer New York

ER -

Low-dose contrast-enhanced MR angiography

Abstract

Access to Document

Fingerprint

Cite this